4dmedical Ltd. · ASX:4DX
4dmedical — Shareholder Meeting (January 2024)
28 slides from 4dmedical's shareholder meeting presentation, Jan 22, 2024
Slide 1: Presentation and Chair's address to Extraordinary General Meeting
ASX announcement ASX:4DX Presentation and Chair’s adddress to Extraordinary General Meeting 22 January 2024 Melbourne, Australia, 22 January 2024: Respiratory imaging technology company 4DMedical Limited (ASX:4DX, “4DMedical”, or the “Company”) attaches the following materials to be presented at the
Slide 2: Chair's Address
4DMedical Limited Extraordinary General Meeting Chair’s Address Ms Lil Bianchi 10.00AM, Monday, 22 January 2024 Thank you for your time today. We called this meeting following our acquisition of Imbio, funded by a capital raise. For personal use only Imbio is a U.S. MedTech recognised as a leader in
Slide 3: Chair's Address: reimbursement, ANZ distribution and FDA
In November we achieved a major reimbursement milestone. We secured US$299 per scan for Medicare & Medicaid Services schedule; providing health coverage to U.S. adults over 65 covering around 65m people. This removes a barrier to accessing XV LVAS, reduces out-of-pocket payments, and is the key to a
Slide 4: Chair's Address conclusion
Imbio’s customer base can accelerate new customers for XV Technology products. The five areas I’ve highlighted demonstrate progress 4DM is making against an ambitious strategy. Approval of the resolutions tabled today enable this significant progress to be sustained. On behalf of the Board thank you
Slide 5: The future of lung health
For personal use only The future of lung health 4DMedical Limited (ASX:4DX) Extraordinary General Meeting 22 January 2024 4DMedical Limited ABN 31 161 684 831
Slide 6: Disclaimer
Disclaimer This presentation has been prepared by 4DMedical Limited (ACN 161 684 831) (Company or 4DMedical). This presentation contains summary information about the Company, its subsidiaries and the entities, businesses and assets they own and operate (Group) and their activities current as of 22
Slide 7: Overview
For personal use only Overview
Slide 8: Agenda
Agenda 1. Opening & introductions For personal use only 2. Chair’s address 3. CEO address 4. Procedural matters 5. Formal business 6. Closing remarks 4
Slide 9: Board of Directors and Key advisors
Board of Directors Key advisors Significant medical and commercial sector experience Medical experts Dr SAM HUPERT MBBS Advisory Board Member For personal use only Co-founder and Chief Executive Officer of Pro Medicus Ltd (ASX:PME) which develops and markets health imaging software primarily for rad
Slide 10: Chair's address
Chair’s address For personal use only LIL BIANCHI Non-Executive Chair Experienced contributor of business transformations for US listed technology companies with a beneficial technology product expertise in AI and SaaS offerings.
Slide 11: Chief Executive Officer
Chief Executive Officer For personal use only Dr ANDREAS FOURAS PhD Managing Director Award-winning aerospace engineer and innovator responsible for the conception and development of 4DMedical’s core technologies.
Slide 12: 4DMedical Limited (ASX:4DX) - introduction
4DMedical Limited (ASX:4DX) - introduction ➢ Who is 4DMedical: ▪ Software technology company commercialising its patented imaging platform, XV Technology® ▪ Allows physicians to diagnose, treat and manage patients more effectively, For personal use only more efficiently and at lower cost than existi
Slide 13: XV Technology advantages
XV Technology® advantages For personal use only New medical insights Improved safety Superior results Functional insight of Comparable radiation High-detail resolution spirometry at a regional level dose to X-ray of a CT scan Patient outcomes Time efficient Low cost Improved clinical Faster, more ef
Slide 14: Material acceleration in commercialisation across 2Q FY2024
Material acceleration in commercialisation across 2Q FY2024, with Imbio acquisition a step change Objective: Become the standard of care for lung diagnosis across both ventilation and perfusion For personal use only Imbio Acquisition Recent developments validate commercialisation strategy: ➢ Focus o
Slide 15: Philips collaboration established with signing of Teaming Agreement
Philips collaboration established with signing of Teaming Agreement ➢ Details: For personal use only ▪ Focus of the agreement will be to offer 4D lung imaging as a critical screening solution for Veterans exposed to burn pits. ▪ Combined commercial product solutions from Philips and 4DMedical provid
Slide 16: Imbio acquisition highlights
Imbio acquisition highlights Function + Structure For personal use only Commercialisation Growth opportunity ‘Owning the lung’ Deliver XV Technology® into Potential to provide screening Additional 4 lung diagnostic established Imbio contracts, program offerings across COPD, products, resulting in a
Slide 17: Summary – substantial progress in commercialisation
Summary – substantial progress in commercialisation ➢ Reimbursement of XV ahead of schedule with increased payment and removes largest barrier to commercialisation in US For personal use only ➢ FDA approval of CT LVAS™ - expansion into US, following Australian model ➢ Philips agreement leverages sca
Slide 18: Procedural matters
For personal use only Procedural matters
Slide 19: Formal business
For personal use only Formal business
Slide 20: Items of Business
Items of Business Item 1: Ratification of issue of Shares under the Placement For personal use only Item 2: Approval for the proposed issue of New Options under the Placement Item 3: Approval for the proposed issue of Earn Out Shares Item 4: Approval for the proposed issue of Options to Director in
Slide 21: Formal business: Item 1 Ratification of Placement shares
Formal business Item 1: Ratification of issue of Shares under the Placement To consider, and if thought fit, to pass, the following as an ordinary resolution: For personal use only “That, for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of Shares under t
Slide 22: Formal business: Item 2 New Options under the Placement
Formal business Item 2: Approval for the proposed issue of New Options under the Placement To consider, and if thought fit, to pass, the following as an ordinary resolution: For personal use only “That, in accordance with Listing Rule 7.1 and for all other purposes, Shareholders approve the proposed
Slide 23: Formal business: Item 3 Earn Out Shares
Formal business Item 3: Approval for the proposed issue of Earn Out Shares To consider, and if thought fit, to pass, the following as an ordinary resolution: For personal use only “That, in accordance with Listing Rule 7.1 and for all other purposes, Shareholders approve the proposed issue of the Ea
Slide 24: Formal business: Item 4 Options to Dr Geraldine McGinty
Formal business Item 4: Approval for the proposed issue of Options to Director in lieu of base directors’ fees – Dr Geraldine McGinty For personal use only To consider, and if thought fit, to pass, the following as an ordinary resolution: “That for the purposes of Listing Rule 10.14 and for all othe
Slide 25: Formal business: Item 5 Options to Ms Lil Bianchi
Formal business Item 5: Approval for the proposed issue of Options to Director in lieu of base directors’ fees – Ms Lil Bianchi For personal use only To consider, and if thought fit, to pass, the following as an ordinary resolution: “That for the purposes of Listing Rule 10.14 and for all other purp
Slide 26: Formal business: Item 6 Long Term Incentive Plan renewal
Formal business Item 6: Approval for the renewal of the 4DMedical Limited Long Term Incentive Plan and the proposed issue of securities under the plan For personal use only To consider, and if thought fit, to pass, the following as an ordinary resolution: “That, for the purposes of Listing Rule 7.2
Slide 27: Poll
For personal use only Poll
Slide 28: 4DMedical Limited (ASX:4DX) Extraordinary General Meeting
4DMedical Limited (ASX:4DX) For personal use only Extraordinary General Meeting 22 January 2024 Copyright ©4DMedical Limited 2024 Level 7, Melbourne Connect 700 Swanston Street Melbourne, Victoria 3053 Australia www.4dmedical.com ABN 31 161 684 831